Statistical methods are critically important for advancing major areas of HIV/AIDS research. This proposal to NIAID aims to develop novel statistical approaches for the design and analysis of studies of the prevention and treatment of HIV infection and associated co-infections. It addresses a key objective of NIAID to help reduce the global impact of HIV/AIDS on society. The following specific aims will be addressed:
Aim 1. To develop statistical methods for prevention studies, including: (1.1) estimating HIV incidence using detuned assays, and (1.2) characterizing transmission in a community by estimating the probability of transmission between infected subjects.
Aim 2. To develop statistical methods for the design and analysis of HIV/AIDS therapeutic studies, in- cluding: (2.1) methods for the joint analysis of efficacy and safety data from HIV studies that handle potentially informative losses to follow-up, (2.2) models and methods for evaluating algorithms for the monitoring of CD4 count and viral load for treatment management, and (2.3) methods for deep sequencing data.
Aim 3. To develop statistical methods for the personalized treatment of HIV-infected patients using data from observational studies. The problems that will be addressed concern major topical issues being confronted in current collaborative research in the treatment and prevention of HIV and associated co-infections.
Under Aim 1, new study de- sign and analysis methods for more reliable estimation of HIV incidence will address methodological issues raised in reports by UNAIDS and the Institute of Medicine, and new methods will be developed to improve understanding of transmission pathways in communities so facilitating better targeting of prevention programs.
Under Aim 2, methods will be developed to allow better assessment of the efficacy and safety of treatments, to evaluate more affordable novel technologies for measuring CD4 counts or viral load that might be used in resource-limited settings (a key priority identified by the World Health Organization), and to advance the im- plementation of deep sequencing technologies for the detection of low frequency drug resistance mutations.
Under Aim 3, the proposed methods can be applied in the many large HIV observational studies to aid in identifying the best treatment for an individual HIV-infected patient. The ultimate goal is to develop practical approaches that can be readily implemented in HIV and co-infection research and, in doing so, help improve programs for the prevention of transmission and the treatment of HIV-infected people.

Public Health Relevance

The research proposal addresses the pressing need for advanced statistical tools that solve study design and analysis challenges being encountered in current HIV research. The development of novel statistical methods that are easy to implement will aid in addressing these challenges and so further the prevention of transmission of HIV and the treatment of people infected with HIV and associated co-infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024643-24
Application #
8298964
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Gezmu, Misrak
Project Start
1987-04-01
Project End
2015-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
24
Fiscal Year
2012
Total Cost
$412,637
Indirect Cost
$84,595
Name
Harvard University
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Carnegie, Nicole Bohme; Wang, Rui; Novitsky, Vladimir et al. (2014) Linkage of viral sequences among HIV-infected village residents in Botswana: estimation of linkage rates in the presence of missing data. PLoS Comput Biol 10:e1003430
Tian, Lu; Zhao, Lihui; Wei, L J (2014) Predicting the restricted mean event time with the subject's baseline covariates in survival analysis. Biostatistics 15:222-33
Moyo, Sikhulile; LeCuyer, Tessa; Wang, Rui et al. (2014) Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. AIDS Res Hum Retroviruses 30:29-36
Wang, Rui; Goyal, Ravi; Lei, Quanhong et al. (2014) Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Clin Trials 11:309-318
Uno, Hajime; Claggett, Brian; Tian, Lu et al. (2014) Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol 32:2380-5
Wang, Rui; Ware, James H (2013) Detecting moderator effects using subgroup analyses. Prev Sci 14:111-20
Zhao, Lihui; Tian, Lu; Cai, Tianxi et al. (2013) EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY. J Am Stat Assoc 108:527-539
Wang, Rui; Weng, Jia; Moyo, Sikhulile et al. (2013) Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. AIDS Res Hum Retroviruses 29:901-6
Gomez, Guadalupe; Lagakos, Stephen W (2013) Statistical considerations when using a composite endpoint for comparing treatment groups. Stat Med 32:719-38
Zhao, Lihui; Hu, X Joan (2013) Estimation with Right-Censored Observations Under A Semi-Markov Model. Can J Stat 41:237-256

Showing the most recent 10 out of 126 publications